LEO receives marketing authorisation application for delgocitinib
The treatment is indicated for adults with moderate-to-severe chronic hand eczema
Read More
Tag: delgocitinib
Positive data from LEO Pharma’s delgocitinib cream trial
Study involves the treatment of adults with moderate-to-severe chronic hand eczema
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
